首页 | 本学科首页   官方微博 | 高级检索  
     


Biweekly doxorubicin/ketoconazole as second-line treatment in docetaxel-resistant, hormone-refractory prostate cancer
Authors:Lainakis George  Nikos Antoniou  Gerassimos Alivizatos  Michael Chrisofos  Iraklis Mitsoyiannis  Konstantinos Livadas  Ioannis Varkarakis  Harilaos Katsifotis  Dimopoulos Meletios A  Bamias Aristotelis
Affiliation:aDepartment of Clinical Therapeutics, University of Athens Medical School, Athens, Greece;bDepartment of Urology, Amalia Fleming Hiospital, Athens, Greece;cDepartment of Urology, University of Athens Medical School, Athens, Greece;dDepartment of Urology, Polykliniki Hospital, Athens, Greece
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号